Manganese(II) phosphate Manganese(II) phosphate Manganese(II) phosphate is an inorganic compound with the chemical formula Mn(PO). It is a rarely studied species, in contrast to the related lithium manganese phosphate, which has been investigated as a battery cathode. Manganese phosphates often combine with iron phosphates through paragenesis. In the process of paragenesis, each mineral affects the manner in which the other is crystallized. The minerals combine in isomorphic series, meaning that they crystallize in similar forms, producing a sequence of solids. Some examples of “isomorphic series” formed by Mn and Fe include heterosite (Fe,Mn)PO, purpurite (Mn,Fe)PO, and triplite (Mn,Fe)PO. The immersion method is
Manganese alloyed with manganese was harder but not more brittle. In 1837, British academic James Couper noted an association between miners' heavy exposure to manganese with a form of Parkinson's disease. In 1912, United States patents were granted for protecting firearms against rust and corrosion with manganese phosphate electrochemical conversion coatings, and the process has seen widespread use ever since. The invention of the Leclanché cell in 1866 and the subsequent improvement of batteries containing manganese dioxide as cathodic depolarizer increased the demand for manganese dioxide. Until the development of batteries with nickel-cadmium and lithium, most batteries contained manganese. The zinc-carbon